Lv1
30 积分 2022-09-02 加入
939P Efficacy and safety of a novel anti-EGFR ADC MRG003 in recurrent or metastatic squamous cell carcinoma of the head and neck patients
1个月前
已关闭
OA10.03 Phase I/II Study of Iza-Bren (BL-B01D1) as Monotherapy in Patients With Locally Advanced or Metastatic EGFR Mutated NSCLC
1个月前
已完结
Final overall survival analysis among patients with folate receptor alpha-positive, platinum-resistant ovarian cancer treated with mirvetuximab soravtansine versus investigator's choice chemotherapy in phase II MIRASOL (GOG-3045/ENGOT-ov55) study
1个月前
已完结
Cancer burden and control in China: landscape, trends and challenges
2个月前
已完结
B cells in systemic lupus erythematosus: from pathogenic mechanisms to targeted therapies
2个月前
已完结
Global, regional, and national incidence and prevalence of systemic sclerosis
3个月前
已完结
Systemic sclerosis: A comprehensive systematic review of global epidemiology, sex and ethnic disparities, disease burden, and organ-specific involvement
3个月前
已完结
ABS0364 SAFETY AND EFFICACY OF T CELL ENGAGER THERAPY IN PATIENTS WITH REFRACTORY AUTOIMMUNE DISEASE
3个月前
已关闭
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
3个月前
已完结
Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain Amyloidosis
9个月前
已完结
皖公网安备34019202002308
